Little Green Pharma Ltd. (AU:LGP) has released an update.
Little Green Pharma Ltd. reports a stellar financial performance with record quarterly cash receipts of $8.1 million, marking a significant increase of over 50% from the previous quarter. The company also achieved a record annual revenue of $25.6 million for FY24, a near 30% rise from the last fiscal year, leading to a positive operating cash flow of $0.5 million. This financial growth coincides with the legalization of cannabis in Germany, contributing to the company’s strong cash position of $5.0 million at the end of March 2024.
For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.
